Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 1,915,000 | 1,764,000 | 1,574,000 | 1,680,000 | 1,655,000 |
| Cost of Goods | 1,418,000 | 1,278,000 | 1,181,000 | 1,253,000 | 1,391,000 |
| Gross Profit | 497,000 | 486,000 | 393,000 | 427,000 | 264,000 |
| Operating Expenses | 280,000 | 182,000 | 189,000 | 154,000 | 204,000 |
| Operating Income | 217,000 | 304,000 | 204,000 | 273,000 | 60,000 |
| Interest Expense | 40,000 | 41,000 | 44,000 | 45,000 | 47,000 |
| Other Income | 54,000 | 17,000 | 140,000 | 3,000 | 31,000 |
| Pre-tax Income | 231,000 | 280,000 | 300,000 | 231,000 | 44,000 |
| Income Tax | 30,000 | 46,000 | 68,000 | 17,000 | -22,000 |
| Net Income Continuous | 201,000 | 234,000 | 232,000 | 214,000 | 66,000 |
| Net Income | $201,000 | $234,000 | $232,000 | $214,000 | $66,000 |
| EPS Basic Total Ops | 1.29 | 1.46 | 1.41 | 1.30 | 0.40 |
| EPS Basic Continuous Ops | 1.29 | 1.46 | 1.41 | 1.30 | 0.40 |
| EPS Diluted Total Ops | 1.26 | 1.43 | 1.37 | 1.27 | 0.39 |
| EPS Diluted Continuous Ops | 1.26 | 1.43 | 1.38 | 1.27 | 0.39 |
| EBITDA(a) | $291,000 | $380,000 | $282,000 | $354,000 | $142,000 |